Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Arcus Biosciences, Inc.
Arcus Biosciences, Inc.
Neomorph, Inc
AstraZeneca
Bristol-Myers Squibb
Xencor, Inc.
Nuvectis Pharma, Inc.
Psyence Australia Pty Ltd
Pfizer
Arcus Biosciences, Inc.
Pfizer
Pfizer
Tizona Therapeutics, Inc
A2 Biotherapeutics Inc.
AstraZeneca
Merck Sharp & Dohme LLC
Takeda
Adela, Inc
HiberCell, Inc.
Second Life Therapeutics
Elephas
Novartis
Kura Oncology, Inc.
Elephas
HistoSonics, Inc.